Vale Brad 4
4 · NEVRO CORP · Filed Mar 3, 2021
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Vale Brad
Director
Transactions
- Sale
Common Stock
2021-03-01$166.05/sh−503$83,524→ 11,831 total - Sale
Common Stock
2021-03-01$167.04/sh−2,012$336,090→ 9,819 total - Sale
Common Stock
2021-03-01$168.32/sh−1,278$215,108→ 8,541 total - Sale
Common Stock
2021-03-01$169.08/sh−1,510$255,317→ 7,031 total
Footnotes (6)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $165.49 to $166.405, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,376 restricted stock units.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $166.64 to $167.15, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $167.86 to $168.767, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $168.905 to $169.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.